Biohit
1,925EUR4.490 investorer følger denne virksomhed
Biohit is a medical technology company. The company develops and manufactures laboratory equipment, supplies, and diagnostic analysis systems adapted for research, care, and industrial laboratories. In addition to the main activities, technical support, maintenance, and training services are offered within the mentioned work area. The largest presence is in the Nordic market. The company is headquartered in Helsinki.
P/E (23e)
18,13
EV/EBIT (adj.) (23e)
12
P/B (23e)
3,17
Udbytteafkast, % (23e)
-
Kursmål
2.40 EUR
Anbefaling
Akkumulér
Opdateret
10.8.2023
NASDAQ Helsinki
BIOBV
Daglig lav / høj pris
-
Markedsværdi
23,37 mio. EUR
Aktieomsætning
-
Volumen
-
Risiko og anbefaling
HøjRisikoLav
SælgAnbefalingKøb
Seneste analyser
Extensive report
Inderes' extensive report is an investor's handbook on customer companies covered by our research.
The latest extensive report was released
Read the reportAnalyst

Antti Siltanen
Analytiker
Seneste videoer
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Biohit Healthcare (Hefei) Co., Ltd. | 32,7 % | 29,4 % |
Suovaniemi Osmo Antero | 13,4 % | 56,3 % |
Premium
Not activated
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Panu Hendolin | 24.08.2023 | 6.390EUR |
Panu Hendolin | 23.08.2023 | 800EUR |
Premium
Not activated
This content is for our Premium customers only.
Resultatopgørelse
2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
---|---|---|---|---|---|---|---|---|
Omsætning | 10,05 | 7,12 | 9,36 | 10,95 | 12,40 | 13,63 | 14,79 | 15,90 |
vækst-% | 1,22 % | -29,14 % | 31,42 % | 16,99 % | 13,23 % | 9,90 % | 8,52 % | 7,52 % |
EBITDA | 0,59 | -1,18 | 0,51 | 1,61 | 2,36 | 2,62 | 3,13 | 3,72 |
EBIT (adj.) | -1,41 | -3,17 | -1,48 | 1,13 | 1,91 | 2,17 | 2,63 | 2,88 |
EBIT | -1,41 | -3,17 | -1,48 | 1,13 | 1,91 | 2,17 | 2,63 | 2,88 |
Overskud før skat | -1,23 | -3,26 | -1,30 | 0,87 | 2,11 | 2,17 | 2,63 | 2,88 |
Netto indkomst | -1,42 | -3,31 | -1,50 | 0,60 | 1,61 | 1,97 | 2,10 | 2,30 |
EPS (adj.) | -0,09 | -0,22 | -0,10 | 0,04 | 0,11 | 0,13 | 0,14 | 0,15 |
vækst-% | 165,85 % | 22,99 % | 6,42 % | 9,51 % | ||||
Udbytte | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,05 | 0,06 | 0,07 |
Udbytte ratio | 38,28 % | 43,17 % | 45,99 % |
Profitability and return on capital
2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 5,91 % | -16,52 % | 5,43 % | 14,69 % | 18,99 % | 19,25 % | 21,17 % | 23,38 % |
EBIT-% (adj.) | -14,05 % | -44,56 % | -15,81 % | 10,30 % | 15,36 % | 15,95 % | 17,76 % | 18,09 % |
EBIT-% | -14,05 % | -44,56 % | -15,81 % | 10,30 % | 15,36 % | 15,95 % | 17,76 % | 18,09 % |
ROE | -9,23 % | -28,25 % | -18,55 % | 8,05 % | 19,18 % | 19,44 % | 17,78 % | 17,45 % |
ROI | -8,89 % | -25,92 % | -17,70 % | 14,27 % | 20,73 % | 19,77 % | 20,45 % | 20,17 % |
Værdiansættelse
2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 3,36 | 2,48 | 1,84 | 1,57 | 1,93 | 1,93 | 1,93 | 1,93 |
Aktier | 15,05 | 15,05 | 15,05 | 15,05 | 15,11 | 15,11 | 15,11 | 15,11 |
Markedsværdi | 50,55 | 37,31 | 27,61 | 23,62 | 29,09 | 29,09 | 29,09 | 29,09 |
Enterprise value | 41,88 | 31,62 | 22,27 | 18,34 | 22,85 | 21,39 | 20,50 | 19,64 |
EV/S | 4,17 | 4,44 | 2,38 | 1,67 | 1,84 | 1,57 | 1,39 | 1,24 |
EV/EBITDA | 70,50 | - | 43,83 | 11,40 | 9,70 | 8,15 | 6,55 | 5,28 |
EV/EBIT (adj.) | - | - | - | 16,26 | 12,00 | 9,84 | 7,81 | 6,83 |
EV/EBIT | - | - | - | 16,26 | 12,00 | 9,84 | 7,81 | 6,83 |
P/E (adj.) | - | - | - | 39,30 | 18,13 | 14,74 | 13,85 | 12,65 |
P/E | - | - | - | 39,30 | 18,13 | 14,74 | 13,85 | 12,65 |
P/B | 3,45 | 4,24 | 3,74 | 3,12 | 3,17 | 2,61 | 2,33 | 2,10 |
P/S | 5,03 | 5,24 | 2,95 | 2,16 | 2,35 | 2,13 | 1,97 | 1,83 |
Udbytteprocent | 2,60 % | 3,12 % | 3,64 % | |||||
Equity ratio | 84,41 % | 81,57 % | 76,71 % | 68,68 % | 73,36 % | 76,17 % | 77,58 % | 78,94 % |
Gearing ratio | -59,18 % | -64,71 % | -72,42 % | -69,82 % | -68,04 % | -69,17 % | -68,83 % | -68,11 % |
Kvartalsdata
Q1/22 | Q2/22 | Q3/22 | Q4/22 | 2022 | Q1/23e | Q2/23 | Q3/23e | Q4/23e | |
---|---|---|---|---|---|---|---|---|---|
Omsætning | 6,10 | -6,10 | 10,95 | 10,95 | 6,50 | 5,90 | |||
EBITDA | 1,50 | -1,50 | 1,61 | 1,61 | 1,75 | 0,66 | |||
EBIT | 1,30 | -1,30 | 1,13 | 1,13 | 1,50 | 0,41 | |||
Overskud før skat | 1,10 | -1,10 | 0,87 | 0,87 | 1,50 | 0,41 | |||
Netto indkomst | 0,90 | -0,90 | 0,60 | 0,60 | 1,40 | 0,31 |
ViserAlle indholdstyper